Achievement of high-quality home spirometry in patients with asthma: The NuvoAir platform
Introduction Self-monitoring has a recognized place in achieving asthma control. Traditionally, patients record symptoms and peak flow measurement in a paper diary, which they use to adjust therapy in accordance with written asthma plans. Telemonitoring augments disease management by facilitating pa...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
European Publishing
2023-11-01
|
Series: | Pneumon |
Subjects: | |
Online Access: | http://www.pneumon.org/Achievement-of-high-quality-home-spirometry-in-npatients-with-asthma-The-NuvoAir,174605,0,2.html |
Summary: | Introduction
Self-monitoring has a recognized place in achieving asthma
control. Traditionally, patients record symptoms and peak flow measurement
in a paper diary, which they use to adjust therapy in accordance with written
asthma plans. Telemonitoring augments disease management by facilitating
patients to record their level of asthma control electronically, supporting remote
physician consultations. This study evaluated the quality of home-based
spirometry in asthma using the NuvoAir platform (NuvoAir U.S inc, Boston,
M.A., U.S.A.), which consists of a smartphone application, Bluetooth spirometer
(AirNext), and physician portal.
Methods
Consecutive adults with difficult-to-treat or severe asthma were
trained on the AirNext, and were asked to perform home spirometry daily for
the first month and then weekly or on symptom worsening. These analyses
used data from patients who performed their first unsupervised spirometry
within 30 days of their supervised. The grading of the quality of spirometry
sessions was based on the American Thoracic Society Technical Statement.
Results
A total of 10 patients with asthma (four uncontrolled asthma; six
partly controlled [GINA 2018]) were included in this study, 9 (90%) female,
mean age 42.0 ± 10.7 years, with FEV1 69.6 ± 26.2% (range: 27.3–101.0)
predicted at the supervised session. Patients performed 1235 unsupervised
sessions over 181.5 ± 153.9 days (maximum 382 days), 877 (71.0%) of which
were acceptable quality, the majority of these (556) being Grade A.
Conclusions
Overall our data show that unsupervised home spirometry
can provide high quality results. More studies are needed to assess home
unsupervised spirometry in larger populations and determine whether it may
lead to improved patient outcomes. |
---|---|
ISSN: | 1105-848X 1791-4914 |